Author

Wei Shi

Institutions: The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine, Guangxi University of Chinese Medicine

Observed institutions: China Pharmaceutical University, The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine, Guangxi University of Chinese Medicine, Second Affiliated Hospital of Zhejiang University, State Key Laboratory of Natural Medicine, Zhejiang University

ORCID: 0009-0007-6568-0819

Observed ORCIDs: 0009-0007-6568-0819, 0000-0002-4083-9105

OpenAlex ID: A5082589142

Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients

2025 · Liping Zhong, Lu Gan, et al. · Cell · 111

Tumor Customized 2D Supramolecular Nanodiscs for Ultralong Tumor Retention and Precise Photothermal Therapy of Highly Heterogeneous Cancers

2022 · Peng Lin, Yucheng Xue, et al. · Small · 25

Exosomal miR ‐ 196a‐5p enhances radioresistance in lung cancer cells by downregulating NFKBIA

2023 · Fei Yao, Wei Shi, et al. · The Kaohsiung Journal of Medical Sciences · 22

A radical photochromic metal–organic framework for boosting NIR-II photothermal conversion and therapy

2022 · Hao Zhang, Linghua Zhang, et al. · Chemical Communications · 14

Upregulation of TTYH3 by lncRNA LUCAT1 through interacting with ALYREF facilitates the metastasis in non-small cell lung cancer

2025 · Fang Fang, Mei Zhao, et al. · Cancer Biology & Therapy · 12

Tumor Customized 2D Supramolecular Nanodiscs for Ultralong Tumor Retention and Precise Photothermal Therapy of Highly Heterogeneous Cancers (Small 21/2022)

2022 · Peng Lin, Yucheng Xue, et al. · Small

Works count: 6

Citation count: 184

H-index: 5

I10-index: 5